Director/PDMR Shareholding

RNS Number : 7092X

Reckitt Benckiser Group PLC

09 May 2016

 

9 May 2016

RECKITT BENCKISER GROUP PLC

 DIRECTOR/PDMR SHAREHOLDINGS

Reckitt Benckiser Group plc (the "Company" or "RB") announces the following changes in the interests of Directors and Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

Vesting and Release of Restricted Share Awards

Following the assessment of the Compound Average Annual Growth in EPS performance condition over the three year period ended 31 December 2015 and confirmation of vesting of 80% at the Company's Annual General Meeting held on 5 May 2016, the following awards made under the Reckitt Benckiser Group 2007 Long-Term Incentive Plan vested and Shares were released on 6 May 2016:

Name	Director/PDMR	Date of Grant of Award	Number of Shares
Rakesh Kapoor	Director	3 Dec 2012	164,514
Adrian Hennah	Director	13 Feb 2013	37,016
Rob de Groot	PDMR	3 Dec 2012	49,354
Amedeo Fasano	PDMR	3 Dec 2012	37,016
Frederic Larmuseau	PDMR	3 Dec 2012	33,417
Deborah Yates*	PDMR	5 Dec 2011	411
Deborah Yates	PDMR	3 Dec 2012	823

* Award was granted prior to becoming a PDMR and eligible for retesting.

The Shares noted below were sold on 6 May 2016 at £66.6992 per share in order to realise sufficient funds to settle resultant tax and social security liabilities arising from such issue:

Name	Number of Shares sold
Rakesh Kapoor	77,459
Adrian Hennah	17,429
Rob de Groot	17,998
Amedeo Fasano	17,429
Frederic Larmuseau	956
Deborah Yates	607

A further 7,587 Shares were disposed of by Mr Fasano on 9 May 2016 at £68.3033 per share.

Following the transactions detailed above, total holdings for the Directors and PDMRs noted above are as shown below:

Name	Number of Shares	Percentage of Issued Share Capital (excl Treasury Shares)
Rakesh Kapoor	562,068	0.0797%
Adrian Hennah	56,438	0.0080%
Rob de Groot	313,425	0.0444%
Amedeo Fasano	200,076	0.0283%
Frederic Larmuseau	144,169	0.0204%
Deborah Yates	1,815	0.0002%

For further Information:

Chris Logan
Company Secretary
[phone]

Richard Joyce

SVP, Investor Relations, Communications & External Affairs

[phone]

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

 

END

 

 

DSHBRGDUGGGBGLC